Minerva Neurosciences (NERV) Total Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences has reported Total Non-Current Liabilities for 11 years, with the latest figure at $283.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 14437.98% year-over-year to $283.1 million; the trailing twelve-month figure through Mar 2026 stood at $283.1 million (up 14437.98% YoY), and the FY2025 full-year result was $173.8 million, up 176.52% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $283.1 million, up from $173.8 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $283.1 million in Q1 2026, with the low at $1.4 million in Q4 2022.
• Historically, Total Non-Current Liabilities has averaged $32.9 million across 5 years, with a median of $3.2 million in 2022.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 55.04% — and 2026, when it jumped 14437.98%.
• Minerva Neurosciences' Total Non-Current Liabilities stood at $1.4 million in 2022, then soared by 142.49% to $3.3 million in 2023, then jumped by 1781.11% to $62.8 million in 2024, then jumped by 176.52% to $173.8 million in 2025, then soared by 62.92% to $283.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $283.1 million (Q1 2026), $173.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.